Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Samaha Eli
Over the trailing 90 days, Samaha Eli (10% Owner at Theravance Biopharma, Inc.) traded $5.8M of stock (net selling $5.8M) across 2 companies, per 5 SEC Form 4 transactions.
- Role
- 10% Owner
- Window
- Trailing 90 days · 5 transactions · CIK 1877589
- Net activity
- −$5.8M ($20K bought · $5.8M sold)
By Company (Trailing 90 Days)
Transactions (5)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-07-01 | STGW | Buy | 2.7K | $20K | Grant, award or other acquisition |
| 2026-07-01 | TBPH | Sell | 37.8K | $643K | Open market or private sale |
| 2026-06-30 | TBPH | Sell | 25.0K | $429K | Open market or private sale |
| 2026-06-29 | TBPH | Sell | 273.9K | $4.7M | Open market or private sale |
| 2026-06-11 | STGW | Buy | 23.0K | $0 | Grant, award or other acquisition |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Samaha's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.